News CCL19 as a Biomarker May Track IgG4-Related Disease Activity by Medscape • 2026/06/10 • 0 Comments CCL19 emerges as a promising biomarker that distinguishes active disease from treatment-induced remission and may help to identify relapsing disease in patients with IgG4-related disease. Medscape Medical News